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Advances in cardiac surgical techniques and perioperative intensive care have led to improved survival in babies with congenital
heart disease (CHD). While it is true that the majority of children with CHD today will survive, many will have impaired
neurodevelopmental outcome across a wide spectrum of domains. While continuing to improve short-term morbidity and
mortality is an important goal, recent and ongoing research has focused on deﬁning the impact of CHD on brain development,
minimizing postnatal brain injury, and improving long-term outcomes. This paper will review the impact that CHD has on the
developingbrainofthefetusandinfant.Neurologicabnormalitiesdetectablepriortosurgerywillbedescribed.Potentialetiologies
of these ﬁndings will be discussed, including altered fetal intrauterine growth, cerebral blood ﬂow and brain development,
associated congenital brain abnormalities, and risk for postnatal brain injury. Finally, reported neurodevelopmental outcomes
after surgical repair of CHD will be reviewed.
1.Introduction
Congenital heart disease (CHD) has been reported to occur
in 5 to 8 per 1000 live births [1]. It is by far the most
common birth defect and a signiﬁcant cause of childhood
morbidity and mortality. Over the past several decades,
advances in cardiac surgical techniques and perioperative
intensive care have led to improved survival in babies with
CHD [1]. While it is true that the majority of children with
CHD today will survive, up to half of surviving children will
have impaired neurodevelopmental outcome across a wide
spectrum of domains [2–5]. While continuing to improve
short-term morbidity and mortality is an important goal,
recent and ongoing research has focused on deﬁning the
impactofCHDonbraindevelopment,minimizingpostnatal
brain injury in this vulnerable population, and improving
long-term outcomes for survivors. This paper will review
the impact that CHD has on the developing brain of the
fetus and infant. Neurologic abnormalities detectable prior
to surgery will be described. Potential etiologies of these
ﬁndings will be discussed, including altered fetal intrauterine
growth, cerebral blood ﬂow and neurodevelopment, high
prevalence of congenital brain abnormalities, and risk for
postnatal brain injury in babies with CHD. Finally, reported
neurodevelopmental outcomes after surgical repair of CHD
will be reviewed.
2.PreoperativeNeurologicalStatusin
BabieswithCHD
Traditionally, studies of neurological outcomes in children
with CHD have focused on factors related to surgery, when
cerebral perfusion may be compromised during cardiopul-
monary bypass. However, the fact that these infants are
at risk for adverse outcome before entering the operating
room is supported by an increasing body of literature.
Brain abnormalities are detectable by preoperative neu-
roimaging and neurological examination in a signiﬁcant
percentage of infants with CHD. These ﬁndings are multi-
factorial, contributed to by intrauterine hemodynamic alter-
ations, congenital brain abnormalities, and acquired brain
injury related to prolonged cyanosis or hypoperfusion after
birth.2 International Journal of Pediatrics
2.1. Clinical and Radiographic Evidence of Impaired Preopera-
tive Neurological Status. Limperopoulos et al. reported neu-
robehavioral abnormalities prior to surgery in 56 newborns
(<1 month at surgery) and 70 infants (between one month
andtwoyears)withcomplexCHDofavarietyoflesiontypes
[6, 7]. In this series, more than 50% of newborns and 38%
of infants were found to have abnormalities. In newborns,
ﬁndings included hypotonia, hypertonia, jitteriness, motor
asymmetry, and absent suck. Sixty-two percent had poor
behavioral state regulation, 34% feeding diﬃculties, and
5% seizures. In infants, abnormalities included hypotonia,
head preference, lethargy, restlessness, agitation, motor
asymmetry, and feeding diﬃculties. Autistic features were
also found. Microcephaly was present in 36%. Newborns
with acyanotic lesions were more likely to demonstrate
abnormalities than those with cyanotic defects. However,
cyanotic infants with an oxygen saturation <85% had a
higher incidence of abnormalities. In another report, these
authors described preoperative neurological examinations
and electroencephalograms (EEG) in 60 infants with CHD.
Prior to surgery, 19% of infants had epileptiform activity,
and 33% had disturbances in background activity that were
moderate or diﬀuse [8]. EEG abnormalities were associ-
ated with abnormal ﬁndings on neurological examination,
and severe abnormalities were predictive of death. Other
authors have likewise reported neurological ﬁndings prior
to surgery in cohorts of patients with CHD. Chock et
al. reported the incidence of an acute neurological event
deﬁned as seizure, tone abnormality, or choreoathetosis, to
be 19% preoperatively in patients of mixed lesion types
[9]. Glauser et al. reported that 38% of infants with
hypoplastic left heart syndrome (HLHS) had an abnor-
mal neurological examination or seizures prior to surgery
[10].
Structural abnormalities and acquired lesions can be
detected by neuroimaging performed prior to surgery in a
signiﬁcant percentage of patients with CHD. Preoperative
head ultrasounds can detect abnormality in 15–59% of
patients with congenital heart disease [9, 11, 12]. Brain mag-
netic resonance imaging (MRI) performed prior to surgery
also demonstrates a high incidence of preoperative brain
abnormalities ranging from 25–53% in some series [13–15].
Lesion types detected preoperatively by ultrasound and MRI
may be either developmental and/or acquired. In addition
to detecting abnormalities, newer imaging modalities may
also shed light on pathogenesis. Emerging MR techniques
including diﬀusion tensor imaging (DTI) and advanced
MR spectroscopy (MRS) have lead to quantiﬁable methods
to describe brain injury. Miller et al. described results of
preoperative DTI and MRS evaluation of 41-term newborns
with CHD compared to healthy control newborns without
CHD [16]. Decreased ratio of N-acetylaspartate to choline,
increased lactate to choline ratio, and decreased white matter
fractional anisotropy values were found, similar to proﬁles
measured in preterm infants. This similarity to the preterm
brain led the authors to suggest that infants with CHD
have abnormal brain development in utero. This concept is
further supported by studies of in utero cerebral blood ﬂow
in fetuses with CHD.
2.2. Intrauterine Factors That Impact Cerebral Flow and
Neurodevelopment. The association of complex CHD with
intrauterine growth retardation has been well established
in numerous reports over the past six decades [17–26].
Biometric data from a regional, population-based, case-
controlled study revealed that infants with CHD had abnor-
mal in utero somatic growth compared to matched controls
[19]. The study demonstrated that infants with transposition
of the great arteries (TGAs) had normal birth weights,
but small head circumferences relative to birth weight.
Newborns with HLHS had birth weights, lengths, and head
circumferences that were less than normal and had head
volumes that were disproportionately small relative to birth
weight. Finally, infants with tetralogy of Fallot (TOF) had
normal proportions, but birth weights, lengths, and head
circumferences that were less than normal. There are two
theories that have been proposed with regards to the etiology
of growth retardation in babies with CHD. First, fetuses with
altered growth may have an increased risk of developing
cardiac abnormalities [17]. Second, and perhaps more likely,
the altered circulation which occurs as a result of the speciﬁc
structural cardiac abnormality can lead to ﬂow disturbances
that may aﬀect in utero growth and brain development
[19, 26]. This second theory has been further explored in
Doppler ultrasound studies of animal and human fetuses.
2.2.1. In Utero Cerebral Flow Characteristics and Compen-
satory Mechanisms. The fetal circulation has been described
in detail in both animal and human studies and is depicted
in Figure 1(a). Fetal lamb studies have shown that right ven-
tricular output is twice left ventricular output, and oxygen
saturation of blood delivered to the cerebral circulation is
higher than that delivered to the body through the ductus
arteriosus. Deoxygenated blood from the superior vena
cava is directed into the right ventricle, across the ductus
arteriosus and to the placenta. The Eustachian valve and
atrial septum move together to direct deoxygenated blood
from the hepatic inferior vena cava into the right ventricle,
and oxygenated blood from the ductus venosus across the
foramen ovale, through the left ventricle, and to the aorta
and cerebral circulation. In the human fetus, the path the
blood takes through the heart is identical. Right ventricular
output is greater than left, though the diﬀerence is not as
substantial as in the fetal lamb [27].
In situations where fetal oxygenation is compromised,
there is a redistribution of blood ﬂow to the cerebral
circulation as a “brain sparing” response [28, 29]. This
hemodynamic phenomenon is represented by increased
diastolic ﬂow in the cerebral arteries and decreased diastolic
ﬂow in the descending aorta and umbilical arteries. Speciﬁc
regions of the fetal brain may be more protected than others.
In a study by Dubiel, interrogation of the middle, anterior,
and posterior cerebral arteries was obtained in pregnan-
cies complicated by maternal hypertension and placental
dysfunction [29]. Cerebral vasodilation was found in the
anterior cerebral artery in 41%, in the posterior cerebral
artery in 30%, and in the middle cerebral artery in 24% of
fetuses evaluated. Thus, there is an enhanced autoregulatory
response of the anterior cerebral arteries, and redistributionInternational Journal of Pediatrics 3
of blood ﬂow favors perfusion of the frontal lobes. The
middle cerebral arteries, however, have been found to be
less reactive and lose reactivity sooner during long-standing
compromise.
Paradoxically, this autoregulatory mechanism has been
found to be a harbinger of adverse neurological outcome.
Since cerebral vasodilation occurs in the face of compro-
mised fetal oxygenation, the detection of this ﬁnding reﬂects
a high risk in utero environment and/or aberrant fetal
circulation. In other words, this protective mechanism may
be inadequate to maintain normal brain growth and devel-
opment in situations of prolonged in utero stress. Doppler
ultrasound studies have elucidated normative data on blood
ﬂowcharacteristicsinhumanfetuses,andabnormalitieshave
been shown to be predictive of adverse perinatal outcome
[30–38]. Resistance and pulsatility indices can both be
calculated from Doppler waveform tracings of the cerebral
vessels obtained during imaging of the fetus. The resistance
index is deﬁned as the systolic ﬂow velocity (SV) minus the
diastolic velocity (DV) divided by the SV. The pulsatility
index is deﬁned as the SV minus the DV divided by the
mean velocity (MV). These indices are considered to be
representative of the resistance to ﬂow distal to the point of
measurement and can be measured in the cerebral as well
as umbilical arterial vessels. Normative information for these
indices has been established and lower than normal values
have been associated with growth retardation [31, 34, 36, 38]
and adverse neurological outcome [33, 36]. A cerebral to
umbilical artery ratio of these indices, reﬂecting degree of
“brain sparing” response, is more predictive of intrauterine
growth restriction and poor outcome than either index
alone. Arbeille showed in normal fetuses that after 15 weeks
gestation the cerebral and umbilical resistance both decrease
linearly, but the cerebral resistance always remains higher
than the umbilical resistance. For the duration of pregnancy
the normal cerebral/umbilical resistance ratio is >1.0. In his
study, 97% of normal fetuses had cerebral/umbilical ratios
>1.0, and 88% of growth-retarded fetuses had ratios <1.0
[38].InastudybyGramellini,acerebral/umbilicalpulsatility
ratio <1.08 after 30 weeks gestation in high-risk pregnancies
had a diagnostic accuracy of 70% for growth retardation and
a predictive value of 90% for poor perinatal outcome [36].
Another ultrasonographic ﬁnding indicative of poor
outcome is reversal of diastolic ﬂow in the aortic isthmus. In
the fetus, the ventricles function in parallel with two distinct
shunt pathways: the foramen ovale and ductus arteriosus.
These connections equalize pressures in the atria and in the
great vessels. Diﬀerences between right and left ventricular
impedance can be explained by the aortic isthmus which is
the narrowest segment of the arch located distal to the left
subclavianarteryandproximaltoductusarteriosusinsertion
[27]. Hemodynamically, the fetal aortic isthmus is the bridge
between the left ventricular and right ventricular outputs.
Normal isthmus blood ﬂow is toward the descending aorta
in diastole. Reversed diastolic ﬂow in the isthmus in the
absence of CHD is likely due to an altered cerebral/placental
resistance ratio caused by placental disease and/or a reﬂex
dilation of the cerebral vasculature in response to hypoxia.
Doppler interrogation with reversed ﬂow at the isthmus has
been shown to be a predictor of poor neurological outcome
in high-risk fetuses [39–41].
2.2.2. Alterations in Cerebral Blood Flow in Fetuses with CHD.
Several studies have characterized in utero blood ﬂow using
Doppler ultrasound in human fetuses with CHD. These
ultrasonographic ﬁndings and their pattern in CHD infants
are summarized in Table 1.
Donofrio et al. published the ﬁrst multicenter, prospec-
tive study that assessed cerebral blood ﬂow by imaging
fetuses with CHD at four-week intervals and comparing
results to normal controls [42]. Sixty-three studies in 36
heart disease fetuses and 47 studies in 21 normal fetuses were
analyzed.Bloodﬂowcharacterizationbylesiontype,changes
during gestation, and comparisons of indices in CHD versus
normal control fetuses were described.
Normal fetal circulation directs oxygenated blood to the
brain and deoxygenated blood to the placenta (Figure 1(a)).
Fetuses with HLHS likely have increased resistance to
cerebral ﬂow as blood ﬂows retrograde across a hypoplastic
aortic isthmus to reach the brain. Due to intracardiac
mixing, relatively deoxygenated blood supplies the cerebral
circulation (Figure 1(b)). Fetuses with left ventricular out-
ﬂow tract obstruction have varying degrees of resistance to
aortic ﬂow, with minimal intracardiac mixing (Figure 1(c)).
Fetuses with TGA have venous blood from the cerebral
c i r c u l a t i o nd i r e c t e db a c kt ot h eb r a i n( Figure 1d). In fetuses
with TOF and hypoplastic right heart syndrome relatively
deoxygenated blood enters the cerebral circulation due to
intracardiacmixing(Figures1(e)and1(f)).Thus,lesiontype
aﬀects not only the source of cerebral blood ﬂow but also
the degree of deoxygenated blood distributed through the
cerebral circulation.
Donofrio demonstrated that the cerebral/umbilical resis-
tance ratio versus gestational age relationship was diﬀerent
between normal and heart disease fetuses. Plotting of the
data revealed a more quadratic eﬀect in fetuses with heart
diseaseversusthelinearrelationshipinfetuseswithoutCHD.
The resistance ratio nadir for heart disease fetuses was at 24-
week gestation (Figure 2). This ﬁnding is signiﬁcant since
brain development enters a critical period at approximately
24–26-week gestation. Rudolph showed that in normal lamb
fetuses, blood ﬂow to the brain begins to increase at a
gestational age which correlates to a human age of 26
weeks [27]. Mari showed that cerebral pulsatility decreases
in normal fetuses after 24 weeks, indicating increased blood
ﬂow to the brain [34]. From 20 to 24 weeks, neuronal
proliferation and migration occur, and by 24 weeks the
human cerebral cortex has its full complement of neurons.
After neuronal migration, the major gyri form between 24–
28 weeks gestation with the most rapid increase occurring at
about 26 weeks [43]. Thus, autoregulation of cerebral blood
ﬂow in fetuses with CHD occurs during a time of brain
development when increased perfusion is needed the most
to compensate for cerebral hypoxemia.
Overall, mean cerebral artery resistance and mean
cerebral/umbilical resistance ratios were lower for fetuses
with heart disease compared to normal. When comparing
individual groups, mean cerebral/umbilical resistance ratios4 International Journal of Pediatrics
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Figure 1: (a) Normal fetal blood ﬂow. (b) Hypoplastic left heart syndrome. (c) left ventricular outﬂow obstruction. (d) Transposition of the
Great Arteries. (e) tetralogy of fallot. (f) hypoplastic right heart. Red arrows: oxygenated blood; blue arrows: deoxygenated blood.
were lower for fetuses with HLHS compared to normal.
Fetuses with TGA had the second lowest mean ratios, with
a trend towards signiﬁcance. The percent of fetuses in
each group with at least one abnormal cerebral/umbilical
resistance ratio during gestation was diﬀerent when com-
paring normal and heart disease groups (5% versus 44%,
resp.). In this analysis, fetuses with hypoplastic left and
right heart syndrome had the highest incidence of abnormal
cerebral/umbilical resistance ratios (58% in HLHS and 60%
in hypoplastic right heart syndrome). Fetuses with TOF
and TGA were less aﬀected (45% and 25%, resp.), and
no fetus with left ventricular outﬂow tract obstruction had
an abnormal resistance ratio. Mean head circumference
to fetal weight ratio trended towards being smaller when
comparing normal and heart disease fetuses. Abnormal
cerebral/umbilical resistance ratios at fetal weights around
2kg were associated with smaller head circumferences in
CHD fetuses.
The second study to evaluate cerebral blood ﬂow in
fetus with CHD was a cross-sectional, prospective analysis
o ff e t u s e sw i t hH L H S( n = 28), and defects with left
(n = 13) or right (n = 17) heart obstruction compared to
114 normal controls published by Kaltman [44]. Cerebral
(CPI) and umbilical pulsatility indices (UPI) were measured,
and comparisons were made using Z-scores generated from
published normative data. When comparing groups, the
HLHS group had a lower mean CPI while the right sided
obstruction group had a higher CPI than normal. The left-
sided obstruction group was not diﬀerent from normal.
The right-sided obstructive lesions had a higher mean UPI
while both other heart disease groups were not diﬀerent
from normal. Of note, the UPI/CPI ratio was not diﬀerent
when comparing groups. The ﬁnding of increased CPI in
fetuses with right sided obstructed ﬂow was diﬀerent from
the results of Donofrio’s study. It is possible that cerebral
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ﬂow from the aorta is unobstructed and perhaps increased
from normal. The increase in cerebral resistance may be
due to cerebral autoregulation to limit excessive ﬂow. The
diﬀerence between the ﬁndings of the two studies may be in
part attributable to the fact that in Kaltman’s study, fetuses
with right sided obstruction included those with TOF which
were analyzed separately by Donofrio. Kaltman’s fetuses had
an increased umbilical resistance that was also not found
in Donofrio’s study. In a study by Meise [45] umbilical
resistance was abnormal in some fetuses with heart disease.
The true prevalence of altered placental ﬂow in fetuses with
CHD is not known. Of note, in Meise’s study no diﬀerence
was found in cerebral resistance when comparing normal
to CHD fetuses; however defects were not separated into
physiologic subtypes for analysis.
Other studies have revealed similar ﬁndings. In a study
by Jouannic [46]c e r e b r a lﬂ o wi nf e t u s e sw i t hT G Aw a s
evaluated. CPI in TGA fetuses (n = 23) was compared
to 40 normal matched controls. In this study the CPI was
signiﬁcantly lower in TGA fetuses compared to normal
fetuses. Umbilical Doppler (including UPI) and ductus
venosus ﬂow were normal. This study conﬁrmed the trend
seen in Donofrio’s study and suggests that fetuses with
TGA have cerebral vasodilation likely from cerebral hypoxia
related to the structural cardiac abnormality. In a study by
Modena’s [47], CPI in 71 fetuses with CHD was compared to
matched controls. Cardiac lesions were grouped into defects
with intracardiac mixing of deoxygenated and oxygenated
blood versus those that were considered to have nonmixing
lesions. Abnormal CPI was found in 7% of fetuses with
CHD, versus none with normal hearts. All abnormal CPI
occurred in fetuses with intracardiac mixing suggesting that
hypoxemia plays a role in cerebral vasodilation. Guorong
[48] evaluated 45 fetuses with CHD and compared ﬁndings
to275controls.CPI,UPI,andUPI/CPIratioswerecalculated
and converted to z-scores similar to the study of Kaltman.
They found that fetuses with CHD had normal CPI; however
UPI/CPI ratios were elevated suggesting a redistribution of
the circulation towards the head. Fetuses with CHD com-
plicated by congestive heart failure had low CPI compared
to normal suggesting cerebral vasodilation. They concluded
that cerebraldilation occurs as a result of cerebral hypoxemia
from limited perfusion and that it is both heart function and
typeo fC H Dt h a th a v ea ni m p a cto nf et a lc e r e b ra lb l o o dﬂ o w
distribution and postnatal neurologic outcome.
The results of these studies all demonstrate that alter-
ations in the intracardiac circulation caused by speciﬁc
cardiac defects result in changes in cerebral blood ﬂow char-
acteristics that can be documented by Doppler ultrasound.
The mechanism is complex and likely is related to both the
cerebraloxygencontentofbloodandalsotheoxygendelivery
which is dependent on cardiac function and total combined
cardiac output. In Donofrio’s study, hypoplastic left and
right heart fetuses were the most aﬀected. These defects
both have a single ventricular chamber with intracardiac
mixing of blood and thus lower oxygen content in the
blood that is delivered to the brain. This relative cerebral
hypoxemia may stimulate a decrease in cerebral vascular
resistance that in the presence of an unchanged placental
resistance results in cerebral vasodilation and abnormal
cerebral/umbilical resistance ratios. It has been shown that
the fetal myocardium delivers less active tension, generates a
lower maximum force of contraction, and responds less to
increased preload than mature myocardium [49]. The single
ventricular chamber may not be able to increase combined
ventricular output enough to compensate for the cerebral
hypoxemia caused by intracardiac mixing of blood. This
may lead to abnormal brain development despite cerebral
autoregulation. In HLHS, cerebral perfusion is likely also
limited by the increased resistance caused by the hypoplastic
aortic isthmus. Since the cerebral circulation is supplied
retrogradely, the isthmus may restrict the amount of blood
that can be delivered to the brain, despite the protective
autoregulatory mechanism of the cerebral vascular bed. This
may contribute to the higher incidence of neurodevelop-
mental abnormalities found in these children. In contrast,
fetuses with TGA and TOF were less aﬀected than those
with single ventricles. In these defects, there is intracardiac
mixing of blood in the presence of two ventricles with
no obstruction to antegrade cerebral ﬂow. These hearts
m a yb ea b l et oc o m p e n s a t ef o rt h ec e r e b r a lh y p o x e m i ab y
increasing combined ventricular output. Of note, fetuses
with left ventricular outﬂow tract obstruction were not
aﬀected. These fetuses likely have cerebral blood with near
normal oxygen content and adequate antegrade aortic ﬂow
to support cerebral perfusion.
Ultimately, what is of utmost importance is how much
oxygen and substrate actually reache the brain in fetuses
with CHD. Chock et al. reported that elevated nucleated red
blood cell counts measured after birth (presumably a marker
of the erythropoietic response to chronic in utero hypoxia)
was a signiﬁcant risk factor (odds ratio 7, P = .02) for a
perioperative acute neurological event [9]. Multiple factors
including cardiac output, oxygen content, and hemoglobin
content are all critical factors that will impact on the oxygen
and substrate delivery to the brain, in addition to the relative
resistances of the distal vascular beds. Given the ﬁndings of
neurological abnormalities after birth and before surgery in
these infants (including smaller head circumference, clinical
neurological abnormalities, and radiographic abnormali-
ties), it appears that there is inadequate fetal cerebral oxygen
delivery to support normal brain development even in the
presence of the autoregulatory “brain sparing” response.
Further studies are needed to correlate these alterations
in fetal circulatory dynamics with postnatal neurodevelop-
mental outcome and to see if intervening in cases where
signiﬁcant abnormalities are detected may improve outcome
for this population.
2.3. Congenital Brain and Developmental Abnormalities.
Structural and functional brain abnormalities have been
identiﬁed in babies born with CHD in the neonatal period
prior to surgical repair. In addition, there have been studies
showing that similar abnormalities can be found in fetuses.
These brain abnormalities represent a spectrum of disease
processes with multiple potential etiologies. Abnormalities
indicative of altered development have been noted in addi-
tion to abnormalities relating to injury from embolic events6 International Journal of Pediatrics
Table 1: Doppler indices of cerebral blood ﬂow.
Doppler Ultrasound
Finding Deﬁnition Signiﬁcance Congenital Heart Disease
Cerebral Pulsatility
Index (CPI) (SV-DV)/MV
Lower value associated with
higher mortality, growth
retardation, and poor
neurological outcome
Lower in HLHS and higher in right-sided
obstruction lesions compared to normal [44]
Lower in TGA [46]
Lower in CHD with intracardiac mixing [47]
Lower in CHD fetuses with CHF [48]
Cerebral Resistance
Index (CRI) (SV-DV)/SV Lower value associated with
growth retardation Lower in CHD infants compared to normal [42]
Cerebral/Umbilical
Pulsatility Ratio CPI/UPI
Ratio <1 associated with
growth retardation and
poor perinatal outcome
No diﬀerence [44]
Increased in CHD [48]
Cerebral/Umbilical
Resistance Ratio CRI/URI Ratio <1 associated with
growth retardation
Lower in CHD infants compared to normal
Lowest in HLHS (58% with ratio <1) [42]
Reversal of diastolic ﬂow
in the aortic isthmus
Blood ﬂow away from
the descending aorta
Predicts poor neurological
outcome
Present in HLHS and severe left ventricular (LV)
outﬂow obstruction with LV failure
or hypoxia. In addition, genetic abnormalities have been
incited in both the cause of structural brain defects as well
as leading to fragility of the brain which may increase the
potential for injury.
2.3.1. Genetic Abnormalities Associated with CHD. Genetic
syndromes that have associated neurological abnormalities
are present in many children with CHD [50]. For example,
infants with Trisomy 21, DiGeorge, velocardiofacial (VCFS),
Turner’s, and William’s syndromes have common congen-
ital heart abnormalities and varying degrees of associated
developmental delay. The incidence of CHD in patients with
Trisomy 21 is approximately 40%, with the most common
being defects of the endocardial cushion and ventricular
septum. All infants with Trisomy 21 have mental retardation,
ranging from mild to severe. DiGeorge syndrome and
velocardiofacial syndrome, both caused by a microdeletion
on chromosome 22 and associated with developmental
delay, are also associated with conotruncal defects including
interrupted aortic arch and truncus arteriosus. Turner’s
syndrome(duetoabsenceofanXchromosome)isassociated
with mildly decreased intelligence quotient (IQ) scores and
abnormalities of the aortic valve and coarctation. Finally, in
William’s syndrome, which is due to a chromosome muta-
tion on 7q11 and associated with cognitive and behavioral
abnormalities, common cardiac defects include supravalvar
aortic stenosis and peripheral pulmonary branch stenosis.
Other genetic factors may also place certain patients at
higher risk for CNS injury. There is increasing evidence that
Apolipoprotein E (APOE) is important for neuronal repair.
APOEe2allelecarrierswerefoundtohavesigniﬁcantlylower
Bayley PDI at one year of age after cardiac surgery compared
to those without the allele, suggesting a genetic susceptibility
to brain injury [51].
2.3.2. Clinical Presentation of Preoperative Brain Abnormali-
ties. Abnormalitiesonneurologicalexamhavebeendetected
preoperatively in neonates with CHD. Chock reported an
incidence of an acute neurological event deﬁned as seizure,
tone abnormality, or choreoathetosis, to be 17% in patients
with CHD prior to surgery [9]. In a study of infants with
HLHS by Glaucer, 38% were reported to have an abnormal
neurological exam or seizures prior to surgery [10]. A
prospective study of babies with CHD by Limperopolous
revealed preoperative neurological abnormalities in 50% of
newborns and 38% of infants [6]. Abnormalities included
hypotonia, hypertonia, jitteriness, motor asymmetry, and
absent suck. Sixty-two percent had poor behavioral state
of consciousness regulation, 34% feeding diﬃculties, and
5% seizures. In infants, abnormalities included hypotonia,
head preference, lethargy, restlessness and agitation, motor
asymmetry, and feeding diﬃculties. Autistic features were
found. Abnormalities were independent of hemodynamic
instability. In another study by Limperoupoulos, 19% of
infants had epileptiform activity, and 33% had disturbances
in background activity on electroencephalogram (EEG) that
were moderate or diﬀuse [8].
2.3.3. Structural Brain Abnormalities in Newborns with CHD.
It is well described that there is a high incidence of brain
malformationinbabieswithCHDintheabsenceofadeﬁned
genetic syndrome [52, 53]. These brain ﬁndings may be
due to undeﬁned genetic abnormalities or may relate to
alterationsinthecirculationleadingtoinjuryorabnormalor
delayed brain development. In one autopsy study, multiple
congenital brain anomalies were found in a signiﬁcant
proportion of babies with HLHS [53], including marked
microcephaly (brain weight > 2 standard deviations below
the normal mean) in 27%, abnormal cortical mantle forma-
tionin27%,andovertcentralnervoussystemmalformations
suchasagenesisofthecorpuscallosumorholoprosencephaly
in10%.Theabsenceofdysmorphicfeaturesdidnotpreclude
the presence of central nervous system malformations, and
conversely, the presence of dysmorphic features did not reli-
ablypredict the presence of a brain abnormality in this study.
These structural abnormalities have been detected in living
patients by physical exam and neuroimaging performedInternational Journal of Pediatrics 7
prior to surgery. In a study by Limperopoulos, preoperative
evaluation of babies with CHD excluding HLHS revealed
microcephaly in 36% and macrocephaly in 13% of babies
evaluated [7]. Head ultrasound has detected abnormality
in patients with CHD including cerebral atrophy [11],
echodensities or calciﬁcations in the basal ganglia [11, 12],
and widened ventricular or subarachnoid spaces [9, 12, 52,
53].
Brain MRI performed prior to surgery has also demon-
strated a high incidence of preoperative brain abnormalities.
In a study by Mahle, 24 patients with CHD were studied,
and the only brain anomaly believed to be congenital in
origin was an open operculum which was present in 17%
[14]. In a study by Licht in 25 babies with CHD, 53%
with CHD had developmental and/or acquired brain lesions
including microcephaly (24%), incomplete closure of the
operculum (16%), and PVL (28%) [15]. Miller, using MRS
and diﬀusion tensor imaging (DTI) in neonates with CHD,
found abnormalities similar to the preterm population [16].
Utilizing biochemical ratios, a higher ratio of lactate/choline
and a lower ratio of N-acetylaspartate/choline were found
in CHD patients with TGA or single ventricle physiology
compared to controls. N-acetylasparatate is a marker of
neuronal integrity found in high concentrations in neurons
andisknowntoincreasewithmaturation.Incontrast,lactate
decreases with increasing maturity. These results suggest
ﬁndings of an immature brain in full-term neonates with
CHD. In the same cohort it was also noted that average
diﬀusivity was increased in the CHD neonates. Average
diﬀusivity decreases with development; this is thought to
be due to decreased water content and increased membrane
growth in neuronal and glial cells that accompany brain
maturation. In a study by Licht [54], infants with HLHS
and TGA were evaluated by MRI with outcome measures
being head circumference and total brain maturation score.
The brain maturation score is a published scoring system
that evaluates four parameters that include myelination,
cortical infolding, involution of glial cell migration bands,
and the presence of germinal matrix tissue. In this study,
the mean head circumference was one standard deviation
below normal and the mean total maturation score for
the cohort was signiﬁcantly lower than reported normative
data suggesting a delay in maturation of one month for
babies with CHD. Limperopoulos evaluated 55 fetuses
with CHD using MRI and MRS and compared results to
50 normal fetuses [55]. Fetal intracranial cavity volume,
cerebrospinal ﬂuid volume, and total brain volume were
calculated using 3-dimensinal volumetric MRI, and cerebral
N-acetyl aspartate/choline ratios and cerebral lactate levels
were determined using MRS. Gestational age at study ranged
from 25 to 37 weeks. MRI analysis showed a progressive
decline in age-adjusted total brain volume and intracranial
cavity volume in fetuses with CHD relative to controls. N-
acetyl aspartate/choline ratios increased in CHD fetuses but
were slower to rise than what was seen in normal fetuses. On
multivariable analysis, the cardiac diagnosis and percentage
ofcombinedventricularoutputthroughtheaorticvalvewere
independently associated with total brain volume. Predictors
of lower acetyl N-acetylaspartate/choline ratios included
cardiac diagnosis, absence of antegrade aortic arch ﬂow,
and evidence of cerebral lactate. These results suggest that
in the third trimester fetuses with some forms of CHD,
in particular those with diminished aortic output, have
evidence of impaired development and brain metabolism
and have total brain volumes that are lower than normal.
These ﬁndings noted on fetal MRI by Limperopoulos, and
on neonatal preoperative MRI by Miller and Licht, suggest
that the altered circulation that attends the fetal circulation
in speciﬁc CHD may delay brain maturation and growth and
play a role in the neurodevelopmental impairments of these
patients.
2.4. Acquired Preoperative Brain Injury. In addition to
the developmental lesions previously mentioned, acquired
lesions may be detectable in babies with CHD before surgery
representing injury due to hemodynamic compromise with
or without hypoxia. There have been several studies that
have revealed the presence of hypoxic ischemic injury before
surgicalintervention.Inanautopsystudy,Glauserfoundthat
45% of babies with HLHS, half of whom did not undergo
surgery, had hypoxic ischemic lesions and/or intracranial
hemorrhage [10]. Hypoxic ischemic injury included cerebral
necrosis, periventricular leukomalacia (PVL), and brainstem
necrosis. Lesions detected by cranial ultrasound studies
include intraventricular hemorrhage [9], cerebral atrophy
[11], echodensities or calciﬁcations in the basal ganglia [11,
12], widened ventricular or subarachnoid spaces [9, 12, 52,
53], and ischemic changes [10, 12]. Licht found PVL in 28%
of CHD patients imaged with MRI preoperatively [15]. In
Mahle’sstudy,25%ofpatientshadclearevidenceofischemic
injury including PVL or infarct on brain MRI done before
surgery. Over 50% of patients had elevated lactate on MR
spectroscopy, further evidence of brain ischemia [14]. In one
of the most recent and largest cohort of 62 patients studied
prospectively with MRI, McQuillen described radiographic
evidence of brain injury in 39% of patients, most commonly
stroke followed by white matter injury [13]. The high
incidence of white matter injury, particularly PVL, is notable
in this population and atypical of the pattern in term
newborns who suﬀer hypoxia-ischemia from other causes.
This ﬁnding suggests that some of the acquired brain injuries
in babies with CHD may be related to an abnormality of the
cerebralvascularbedand/orbraindevelopment.Itispossible
that babies with CHD have white matter cell lines that are
particularly susceptible to injury, similar to the vulnerability
of these cells in preterm infants, manifesting in diﬀerent
patterns of injury compared to other term infants who suﬀer
hypoxic ischemic injury.
In addition to neuroimaging evidence of preoperative
brain injury, various serum biomarkers reﬂecting systemic
and neurological compromise have been examined in
patients with CHD. Serum lactate as a marker of global
hypoperfusion has been followed and found to be elevated
preoperatively in patients with CHD [56]. Proinﬂammatory
cytokine proﬁles (with elevated IL-6 and decreased IL-
10) have been detected in infants with cardiac disease
preoperatively [57]. The glial-derived protein S100B has
been evaluated in infants and adults with cardiac disease8 International Journal of Pediatrics
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Figure 2: Cerebral to placental resistance ratio versus gestational age for normal fetuses and fetuses with Congenital Heart Disease (CHD).
∗P is signiﬁcant normal versus CHD.
a n di sb e l i e v e dt ob eam a r k e rf o rc e r e b r a li s c h e m i a[ 58–
60]. S100B levels have been found to be elevated in infants
with CHD before surgery, possibly reﬂecting preexisting
neurological injury [60]. Infants with HLHS had the highest
levels before surgery, and the S100B concentration correlated
inversely with the size of the ascending aorta. This ﬁnding
complements the Doppler studies that suggest that the
amount of antegrade ﬂow in the aorta in fetuses and infants
with HLHS impacts cerebral perfusion and may leave these
infants particularly prone to ischemic injury even before
surgery.
3. Neurodevelopmental Outcome after
SurgicalRepairof CHD
There is an increasing body of literature reporting inter-
mediate and long-term outcomes from various cohorts of
patients with CHD. Generalizations are problematic since
there is heterogeneity amongst these reports in regards to
surgical/medical era, patient population, type of cardiac
lesion, age at followup, and type of assessment tool used.
Given the advances in care including improved medical
and surgical techniques and brain protection strategies, the
more historical data reported may not reﬂect the improved
outcomes that we hope to see with patients in the current
era. Nevertheless, outcome data has provided some general
knowledge about these patients postoperatively, both in the
short-term and for long term survivors.
3.1. Short-Term Neurological Outcome after Surgery. Postop-
erative short-term outcomes include a signiﬁcant incidence
of neurological abnormalities. Miller performed postopera-
tive neurological examinations in 91 infants who had under-
gone heart surgery and found 15% had clinical seizures, 34%
had hypotonia, 7% had hypertonia, 5% had asymmetry of
tone, and 19% had decreased alertness at hospital discharge
[61]. The aforementioned study by Limperopoulos that
detectedhighincidenceofpreoperativeneurologicalﬁndings
also reported that these abnormalities generally persisted or
worsened postoperatively, with additional ﬁndings of cranial
nerveabnormalitiesandchoreoathetosis[6].Chockreported
theincidenceofanacuteneurologicaleventtobe25%within
theﬁrstweekaftersurgeryand56%aftertheﬁrstweek[9].In
other reports, the incidence of clinical post-operative seizure
was 4–11% and was detected by continuous EEG monitoring
in up to 20% of patients in the 48 hours following surgery
[62–67]. Swallow dysfunction [68]o ra b n o r m a ls u c k[ 6]i s
another signiﬁcant ﬁnding in patients with CHD following
surgery, as feeding performance has been shown to be an
early indicator of later neurodevelopmental outcome [69].
3.2. Neurodevelopmental Outcomes for Survivors at School Age
and Beyond. Reports of long-term followup have limited
applicability as technological advances in medical manage-
mentandsurgicalrepairtechniquesmakeoutcomesreported
fromproceduresdoneinpreviousdecadeslessinsightful.For
example, of note when interpreting results of the outcomes
from the Boston Circulatory Arrest Trial is that during the
timeperiodofthestudythealphastatstrategy,hemodilution
to 20% hematocrit, and currently outmoded hardware for
bypass were utilized. Thus, consideration must be made to
surgicalerawheninterpretingresultsfromhistoricalcohorts.
Despite this, some general themes have arisen from reported
long-term outcomes in patients with CHD.
Long-term survivors, although they frequently have
limitations, are actually quite functional. Several studies
have demonstrated that while patients with CHD have
signiﬁcantly lower mean IQs than age-matched controls,
their IQs still fall within the normal range [4, 5, 70–
94]. These reports, however, also describe highly prevalent
gross and ﬁne motor, attention, and school problems. The
prospectivecohortoriginallydescribedbyLimperoulouswas
followed through school age by Majnemer and found to
have high incidence of gross and ﬁne motor abnormalities
(49 and 39%, resp.) and abnormal neurological examination
(28%) [2]. Highly prevalent behavioral and school problems
are reported from the Boston cohort [5, 91]. Overall long-
term cognitive outcomes reported from various studies are
presented in Table 2. Special attention should be paid toInternational Journal of Pediatrics 9
Table 2: Reported long-term cognitive outcomes for patients with congenital heart disease.
Diagnosis Reference Number of
Patients
Mean age at
assessment
(range)
Cohort
prospectively
identiﬁed
Surgical era
Full scale IQ
(mean ± SD) or
median (range)
CHD-mixed Clarkson, 1980 [89] 72 4y (2.4–7y) No 1969–71 93 ± 16
Forbess, 2002 [87] 243 5 y No 1993–2000 97 ± 16
Miatton, 2007 [75] 43 8y No 1995–99 96 ± 15
TGA Clarkson, 1980 [89] 22 4y (2.4–7y) No 1969–71 90 ± 18
Newberger, 1984 [74] 33 5.8y (5.5–6.3y) No 1968–72 102 ± 15
Hesz, 1988 [84] 10 (6.5–14y) No 1967–84 92 ± 12
Oates, 1995 [73] 30 (9–10y) No 1972–82 100 ± 17
Ellerbeck, 1998 [88] 54 8y No 1981–90 90 ± 21
Hovels-Gurich, 1997 [82]
2001 [94]
77
60
5y( 3 – 9 y )
10y (8–14y) Yes 1986–92 99 ± 14
99 ± 17
Bellinger, 1999 [91]
2003 [5]
158
155
4y
8y (7–10y)
Yes
(Boston CA) 1988–92 93+17
97+15
Karl, 2004 [81] 74 9y (4–14y) No 1988–94 102 ± 13
Brosig, 2007 [90] 13 (3.5–6y) No 1996–99 110 (90-126)
Clarkson, 1980 [89] 17 4y (2.4–7y) No 1969–71 88 ± 14
TOF Oates, 1995 [73] 51 (9–10y) No 1972–82 100 ± 17
Hovels-Gurich, 2006 [83] 20 7y (5–12y) Yes 1993–99 91 ± 13
Miatton, 2007 [76] 18 8y No 1994–99 95 ± 14
Clarkson, 1980 [89] 16 4y (2.4–7y) No 1969–71 93 ± 15
TGA/TOF Wright, 1994 [70] 29 9.5y (7–12y) No 1979–84 94 ± 15
VSD Oates, 1995 [73] 33 (9–10y) No 1972–82 102 ± 12
Hovels-Gurich, 2006 [83] 20 7y (5–12y) Yes 1993–99 93 ± 12
SV Wernovsky, 2000 [71] 128 11y (3.7-41y) No 1973–91 96 ± 17
Uzark, 1998 [72] 32 2.5y (1.5–9.5y) No 1986–94 98 ± 12
Goldberg, 2000 [85] 51 5y (2.8–8y) No 1989–96 101 ± 5
Forbess, 2002 [87] 34 5 y No 1993–2000 90 ± 16
HLHS Kern, 1998 [80] 12 4y (3–6y) No 1990–96 80 ± 14
Goldberg, 2000 [85] 26 5y (2.8–8y) No 1989–96 94 ± 7
Mahle, 2000 [78] 28 9y (6–13.6y) No 1984–91 86 (50–116)
Mahle, 2006 [77] 48 12y (8–17y) No 1986–94 86 ± 14
Brosig, 2007 [90] 13 (3.5–6y) No 1996–99 97 (71–112)
outcomes reported for two speciﬁc populations: those with
single ventricles and TGA. Patients with single ventricles,
especially those with HLHS, have higher risk for adverse
outcome based on their underlying physiology and hemody-
namics as well as complexity of surgical repair. Meanwhile,
patients with TGA have been the most extensively and
reliably studied.
3.3. Neurodevelopmental Outcomes in Children with Single
Ventricles. Children with a single functioning ventricle who
undergo a series of palliative surgical procedures culmi-
nating in the Fontan operation are at the highest risk of
developmental compromise. In addition to the frequent
hemodynamic instability accompanying the complex cardiac
physiology in these patients, surgical repair often involves
multiple operations requiring bypass and circulatory arrest.
Children with HLHS are at particular risk for neurodevel-
opmental abnormalities, in part because the repair involves
a period of hypothermic circulatory arrest that in the past
has been longer than 30–40 minutes. There have been several
reports of neurodevelopmental outcomes in these patients
although none involved prospectively identiﬁed cohorts.
Forbess reported outcomes from the registry of outcome
data maintained by the group at Boston Children’s Hospital.
He reported that patients with single ventricle lesions had
signiﬁcantly lower full-scale and performance IQ and had
lower scores on multiple domains of memory, learning and
visual-motortesting, whencomparedto patients undergoing
biventricular repair [87]. Wernovsky evaluated 133 patients
who had a Fontan operation between the years 1973–91
[71]. For 128 patients who underwent cognitive testing, the
mean full scale IQ of 96 was lower than the population10 International Journal of Pediatrics
mean. Mental retardation was found in 8%. Children with
HLHS scored lower on all parameters compared to children
with other single ventricle lesions. Mahle reported results of
outcomes for patients with HLHS who underwent surgery in
1984–1991 [78]. In 28 children, the median full scale IQ was
86, lower than the general population mean. Performance
I Qw a sl o w e rt h a nv e r b a l( 8 3v e r s u s9 0 ) .F u l ls c a l eI Q
scores in the mental retardation range were found in 18%.
Cerebral palsy with hemiparesis was documented in 17%,
microcephaly in 13%, ﬁne motor abnormalities in 48%,
gross motor abnormalities in 39%, and speech deﬁcits in
30%. Goldberg reported IQ scores reﬂecting outcomes for
HLHS in the time period between 1989–94 [85]. Children
with HLHS fell within the normal range for full scale IQ
as measured by the Weschler test but scored lower than
children with other single ventricle lesions. For the whole
group, IQ was 101, for HLHS 94, and for other single
ventricles 107. Brosig reported the most recent outcome
data for patients who underwent surgery between 1993–
99 [90]. Median IQ was 97 in 13 patients evaluated at
3.5 to 6 years. When compared to patients with TGA,
patients with HLHS had more problems with visual-motor
skills, expressive language, attention, and externalizing
behavior.
3.4. Neurodevelopmental Outcomes in Children with TGA.
The majority of neurodevelopmental outcome reports come
from cohorts of patients retrospectively identiﬁed and
recalled for developmental assessments, leading to inherent
selection bias. There are few prospective studies which have
provided more reliable outcome information. The Boston
Circulatory Arrest Trial evaluated diﬀerences between two
groups of babies with TGA based on bypass strategy and
provided insight into the outcomes of babies with TGA
in general after surgical repair [5, 91–93]. The overall
study population had signiﬁcantly lower mean IQ than the
general population although still within the normal range.
Verbal IQ was higher than performance IQ. Although mean
scores on most outcomes were also within normal limits,
the cohort as a whole was performing below expectations
in several domains including academic achievement, gross
and ﬁne motor, working memory, attention, and higher-
order language skills. There was high prevalence of hearing
deﬁcits (12% and 8% in the circulatory arrest and low
ﬂow bypass groups, resp., P = .43) at four years [91]a n d
abnormalities on neurological exam (circulatory arrest 71%
and low ﬂow bypass 64%, P = .23) at eight years [5].
At 8 years following repair, 30% of the population were
receiving remedial services in school, and 10% had repeated
ag r a d e .
In another longitudinal prospective study in Germany,
Hovels-Gurich et al. followed 60 patients with TGA through
school age and have reported outcomes for their group at a
mean of 10 years [4, 82, 94]. While they found that overall
IQ scores were not signiﬁcantly diﬀerent than population
norms(diﬀerentfromtheBostoncohort),theyreportedhigh
r a t e so fg r o s sa n dﬁ n em o t o rd y s f u n c t i o n( >20%), reduced
expressive and receptive language (around 20%), and speech
abnormalities (40%).
4. Conclusion
Advancesinmedicine,includingprenataldiagnosisandeval-
uation, innovations in cardiothoracic surgical techniques,
and improvements in perioperative management have con-
tributed to the increased survival of infants with CHD.
Greater attention is now being directed toward understand-
inghowinuterohemodynamicsaﬀectcerebraldevelopment,
how the conduct of the operation can best be manipulated
to maximize cerebral oxygen delivery and utilization, and
how perioperative care, including the incorporation of
neuromonitoring, can be optimized. Although as a group
IQ appears to be in the normal range for CHD survivors,
rates of neurodevelopmental impairment continue to be
signiﬁcant. Neurodevelopmental evaluation in patients with
CHD should be standard practice to not only identify those
with impairments who would beneﬁt from intervention
services but also to continue to identify risk factors and
strategies to optimize both short- and long-term outcomes
in these high-risk children. In the future, fetal management
andinterventionstrategiesforspeciﬁcdefectsmayultimately
play a role to improve in utero hemodynamics and increase
cerebral oxygen delivery to enhance brain growth and
improve early neurodevelopment.
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